Bing Liang
Impact in
-
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
Papers in
-
- RNA modifications and cancer 3
- Cancer-related gene regulation 2
- Epigenetics and DNA Methylation 2
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Wenhui Qu (1 shared paper)Nan Jiang (2 shared papers)Hanming Wang (1 shared paper)Haijuan Sui (1 shared paper)Ying Jin (1 shared paper)Lingling Zhang (1 shared paper)Yanju Gong (2 shared papers)Min Cai (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (2 papers)European Journal of Pharmacology (2 papers)The American Journal of Chinese Medicine (1 paper)Nursing and Health Sciences (1 paper)Nutrients (1 paper)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Bing Liang
26 papers receiving 279 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 45
- Geriatrics and Gerontology 7
- Toxicology 7
- Complementary and alternative medicine 16
- Biochemistry 11
Countries citing papers authored by Bing Liang
This map shows the geographic impact of Bing Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Liang more than expected).
Fields of papers citing papers by Bing Liang
This network shows the impact of papers produced by Bing Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Liang. The network helps show where Bing Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 41 | |
| 2 | 2019 | 38 | |
| 3 | 2014 | 35 | |
| 4 | 2021 | 33 | |
| 5 | 2022 | 20 | |
| 6 | 2021 | 16 | |
| 7 | 2013 | 16 | |
| 8 | 2024 | 13 | |
| 9 | 2021 | 12 | |
| 10 | 2017 | 12 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 6 | |
| 13 | 2023 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2025 | 4 | |
| 17 | 2025 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2007 | 2 |
About Bing Liang
Bing Liang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Pharmacology and Oncology, having authored 27 papers that have together received 284 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), RNA modifications and cancer (3 papers), Cancer, Lipids, and Metabolism (2 papers), Biological and pharmacological studies of plants (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer-related gene regulation (2 papers), Immune cells in cancer (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (45 citations), Geriatrics and Gerontology (7 citations), Toxicology (7 citations), Complementary and alternative medicine (16 citations) and Biochemistry (11 citations). Bing Liang has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Wenhui Qu, Nan Jiang, Hanming Wang, Haijuan Sui, Ying Jin, Lingling Zhang, Yanju Gong, Min Cai, Hong Li and Hong Chen. Their work appears in journals such as Biomedicine & Pharmacotherapy, European Journal of Pharmacology, The American Journal of Chinese Medicine, Nursing and Health Sciences and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.